Overview

Randomized Study to Evaluate the Efficacy of Fluvastatin on Inflammatory Markers in Patients With Aortic Stenosis.

Status:
Terminated
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
Atherosclerosis and aortic stenosis share inflammatory etiopathogenic characteristics in common. We hypothesized that statins therapy would decrease inflammatory markers concentrations in patients with degenerative aortic stenosis and halt the haemodynamic progression of the disease.
Phase:
Phase 4
Details
Lead Sponsor:
AORTICA Group
Treatments:
Fluvastatin